论文信息 - Dermatopathic Lymphadenopathy Mimicking Disease Progression During Osimertinib Treatment. - 字舞流文

Dermatopathic Lymphadenopathy Mimicking Disease Progression During Osimertinib Treatment.

K. Kunimasa | T. Kumagai | Keiichiro Honma | K. Nishino | M. Matsumoto

[1] K. Patel,et al. Clinical, histopathologic, and immunoarchitectural features of dermatopathic lymphadenopathy: an update , 2020, Modern Pathology.

[2] C. Britschgi,et al. Patterns of progression on osimertinib in EGFR T790M positive NSCLC: A Swiss cohort study. , 2019, Lung cancer.

[3] T. Kohno,et al. Circulating cell-free plasma tumour DNA shows a higher incidence of EGFR mutations in patients with extrathoracic disease progression , 2018, ESMO Open.

[4] R. Compagna,et al. Axillary masses in a woman with a history of breast cancer: dermatopathic lymphadenopathy. , 2014, International journal of surgery.

[5] J. Davoust,et al. Accumulation of Immature Langerhans Cells in Human Lymph Nodes Draining Chronically Inflamed Skin , 2002, The Journal of experimental medicine.